SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    National Cancer Institute. Available at: http://www.cancer.gov/cancertopics/types/non-hodgkin Accessed October 6, 2008.
  • 2
    A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's Lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997; 89: 3909-3918.
  • 3
    Armitage J, Weisenburger D. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. J Clin Oncol. 1998; 16: 2780-2795.
  • 4
    MacManus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol. 1996; 14: 1282-1290.
  • 5
    Petersen PM, Gospodarowicz R, Tsang R, et al. Long term outcome in stage I and II follicular lymphoma following treatment with involved field radiation therapy alone. J Clin Oncol. 2004; 22: 6521.
  • 6
    Vaughan Hudson B, Vaughan Hudson G, MacLennan KA, Anderson L, Linch DC. Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. Br J Cancer. 1994; 69: 1088-1093.
  • 7
    Soubeyran P, Eghbali H, Bonichon F, et al. Localized follicular lymphomas: prognosis and survival of stages I and II in a retrospective series of 103 patients. Radiother Oncol. 1988; 13: 91-98.
  • 8
    Guadagnolo BA, Sigui L, Neuberg D, et al. Long term outcome and mortality trends in early stage, grade 1-2 follicular lymphoma treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2006; 64: 928-934.
  • 9
    National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Non-Hodgkin Lymphoma. Available at: http://www.nccn.org/professionals/physician_gls/PDF/nhl.pdf Accessed October 12, 2008.
  • 10
    Engelhard M, Stuschke M. Report on workshop: UICC workshop “Therapy of NHL in early stages.” Part 1: Follicular lymphoma. Ann Hematol. 2001; 80: 13-15.
  • 11
    Kelsey SM, Newland AC, Hudson GV, Jelliffe AM. A British National Lymphoma Investigation randomized trial of single agent chlorambucil plus radiotherapy versus radiotherapy alone in low grade, localized, non-Hodgkins lymphoma. Med Oncol. 1994; 11: 19-25.
  • 12
    Advani R, Rosenberg SA, Horning SJ. Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy. J Clin Oncol. 2004; 22: 1454-1459.
  • 13
    Horning SJ, Rosenberg SA. The natural history of initially untreated low grade non-Hodgkin's lymphomas. N Engl J Med. 1984; 311: 1471-1475.
  • 14
    Surveillance, Epidemiology, and End-Results Program. Available at: http://seer.cancer.gov/about Accessed October 12, 2008.
  • 15
    Johnson CH, Adamo M. The SEER Program Coding and Staging Manual 2007. National Cancer Institute, NIH Publication number 07-5581. Available at: http://seer.cancer.gov/manuals/2007/SPCSM_2007_maindoc.pdf Accessed October 20, 2008.
  • 16
    Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Handbook. 6th ed. New York, NY: Springer; 2002.
  • 17
    Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood. 2004; 104: 1258-1265.
  • 18
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457-458.
  • 19
    Mantel N. Evaluation of survival data and 2 new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966; 50: 163-170.
  • 20
    Cox DR. Regression models and life-tables. J R Stat Soc [B]. 1972; 34: 187-202.
  • 21
    Peters MV, Bush RS, Brown TC, et al. The place of radiotherapy in the control of non-Hodgkin's lymphomata. Br J Cancer. 1975; 31: 386-401.
  • 22
    Chen MG, Prosnitz LR, Gonzalez-Serva A, Fischer DB. Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma. Cancer. 1979; 43: 1245-1254.
  • 23
    Brice P, Bastion Y, Lepage E, et al. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 1997; 15: 1110-1117.
  • 24
    Ardeshna KM, Smith P, Norton A, et al. British National Lymphoma Investigation: long term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced stage non-Hodkin lymphoma—a randomized control trial. Lancet. 2003; 362: 516-522.
  • 25
    Young RC, Longo DL, Glatstein E, et al. The treatment of indolent lymphomas: watchful waiting versus aggressive combined modality treatment. Semin Hematol. 1988; 25( supp 2): 11-16.
  • 26
    Pendlebury S, el Awadi M, Ashley S, et al. Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphoma. Radiother Oncol. 1995; 36: 167-171.
  • 27
    Seymour JF, Pro B, Fuller LM, et al. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma. J Clin Oncol. 2003; 21: 2115-2122.